Cure CMT
Pat has spent years building Cure CMT alone. The Founding 50 is his ask to change that. The commitment: $5,000, straight to a patient. A full brace. A contribution toward surgery that can cost $100,000 an ankle. No fund, no lag, the money moves to the person who needs it. Then you bring three people with you. Same ask, same commitment. If every Founding 50 member does that, the network triples before the campaign is a month old. Every dollar…
Cure CMT and Bexion Pharmaceuticals Announce Funding to Advance BXQ-350 in Metastatic Colorectal Cancer and Chemotherapy-Induced Peripheral Neuropathy Cure CMT and Bexion Pharmaceuticals announced an investment from Cure CMT to support the continued development of BXQ‑350 in metastatic colorectal cancer (mCRC) and chemotherapy‑induced peripheral neuropathy (CIPN), two areas of significant unmet medical need. In mCRC, BXQ‑350 has demonstrated preliminary clinical activity and, in combination with front‑line standard‑of‑care FOLFOX, met the protocol‑prespecified objective response rate (ORR) criteria required to support advancement…
Join us for the Cure CMT Golf Challenge at Merit Club, in Libertyville, IL, Monday, June 29, 2026. Cure CMT is making a difference by funding leg braces and surgeries for CMT patients, dramatically improving their mobility and quality of life. Cure CMT is also investing in the promising technologies BIO-Pharma has to offer to accelerate the path toward a first treatment/cure! Merit Club 1500 Merit Club Lane Libertyville, IL 60064 10:30 am arrival time Register now
ReviR Therapeutics Receives Strategic Investment from CureCMT to Advance a First-of-its-Kind Precision Medicine Platform for CMT An isogenic iPSC and AI-enabled disease modeling platform spanning multiple genetically defined CMT subtypes will be established to support patient stratification, accelerate RTX-117 development, and create a shared foundation for next-generation therapies BRISBANE, Calif., April 21, 2026 /PRNewswire/ -- ReviR Therapeutics today announced a strategic investment from CureCMT to support the launch of a precision medicine platform for Charcot-Marie-Tooth disease (CMT). The platform will…